MedTrace Logo

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

NCT01968005 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2018-01-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).

Conditions

  • Low Back Pain

Interventions

DRUG

Etoreat®(Etodolac-Lidocaine Topical Patch)

DRUG

Placebo

Sponsors & Collaborators

  • MEDRx USA, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-05-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01968005 on ClinicalTrials.gov